Anavex Life Sciences Corp.

Historical 13F Holders

Symbol
AVXL
CUSIP
032797300
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 032797300 since 12/18/2024, largest first.

Filer % of Class Filed
Vanguard Capital Management LLC 13G 5.0% 7/31/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 11 278 k $444 k
2026 Q2 193 37.0 M $97.1 M
2026 Q1 201 40.0 M $123 M
2025 Q4 203 37.9 M $136 M
2025 Q3 205 32.9 M $301 M
2025 Q2 195 32.5 M $302 M
2025 Q1 202 31.4 M $270 M
2024 Q4 186 29.5 M $316 M
2024 Q3 156 27.0 M $153 M
2024 Q2 157 27.3 M $115 M
2024 Q1 164 32.6 M $165 M
2023 Q4 174 26.7 M $248 M
2023 Q3 156 25.1 M $164 M
2023 Q2 159 25.3 M $206 M
2023 Q1 155 27.1 M $232 M
2022 Q4 157 32.8 M $303 M
2022 Q3 164 24.4 M $252 M
2022 Q2 164 24.9 M $249 M
2022 Q1 157 25.1 M $310 M
2021 Q4 169 22.8 M $396 M
2021 Q3 152 20.6 M $370 M
2021 Q2 143 21.6 M $496 M
2021 Q1 120 18.2 M $273 M
2020 Q4 105 14.1 M $76.6 M
2020 Q3 86 12.7 M $57.7 M
2020 Q2 81 11.9 M $58.8 M
2020 Q1 76 11.7 M $36.8 M
2019 Q4 74 14.5 M $37.6 M
2019 Q3 66 13.4 M $42.6 M
2019 Q2 71 12.2 M $41.3 M
2019 Q1 61 7.38 M $22.5 M
2018 Q4 57 7.01 M $10.9 M
2018 Q3 54 8.21 M $22.3 M
2018 Q2 63 9.18 M $24.1 M
2018 Q1 63 10.3 M $28.5 M
2017 Q4 70 10.1 M $32.6 M
2017 Q3 68 10.0 M $41.5 M
2017 Q2 69 10.3 M $54.7 M
2017 Q1 69 9.42 M $54.1 M
2016 Q4 67 7.64 M $30.3 M
2016 Q3 61 4.58 M $16.6 M
2016 Q2 51 3.83 M $23.4 M
2016 Q1 44 2.16 M $10.6 M
2015 Q4 35 1.37 M $7.63 M